Genomtec S.A. (WSE:GMT)
Poland · Delayed Price · Currency is PLN 5.24
-0.22 (-4.03%)
Oct 31, 2025, 4:37 PM CET
Genomtec Market Cap
Genomtec has a market cap or net worth of 82.25 million as of October 31, 2025. Its market cap has decreased by -17.47% in one year.
Market Cap
82.25M
Enterprise Value
74.74M
Revenue
11.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
5.24
Market Cap Chart
Since March 17, 2021, Genomtec's market cap has decreased from 110.55M to 82.25M, a decrease of -25.60%. That is a compound annual growth rate of -6.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2025 | 82.25M | -21.46% |
| Dec 30, 2024 | 104.73M | -21.25% |
| Dec 29, 2023 | 133.00M | 22.23% |
| Dec 30, 2022 | 108.81M | 42.64% |
| Dec 30, 2021 | 76.28M | -31.00% |
| Mar 17, 2021 | 110.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 6.33B |
| NEUCA | 3.29B |
| Synektik Spólka Akcyjna | 2.25B |
| Voxel | 1.64B |
| Celon Pharma | 1.16B |
| Selvita | 679.15M |
| Centrum Medyczne ENEL-MED | 511.87M |
| Bioceltix | 485.06M |